SCL Science Inc.
Research SCL Science Inc. (246960.KQ) on Bullrun: market cap KRW 73.30B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker246960.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 73.30B
- Financial periodQ2 2026
- RevenueKRW 7.59B
- Net income-KRW 9.40M
- Free cash flowKRW 869.09M
- Gross margin30.3%
Valuation Snapshot
latest market cap is KRW 73.30B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 73.30B | n/a | n/a | n/a |
Dividend history
About SCL Science Inc.
SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasis and sealing products; STOP, a non-bleeding intravascular injection;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SCL Science Inc.'s market cap?
SCL Science Inc.'s market capitalization is KRW 73.30B.
What does SCL Science Inc. do?
SCL Science Inc. produces medical hemostatic agents using biomimetic technology. Its products include BiMM (Bio-inspired Medical Materials) that reacts immediately with blood; Endoseal, which is used for specialized indication of gastrointestinal bleeding; InnoSeal, a hemostatic agent that is used in various surgical fields, such as cardiology, radiology, and neurosurgery; Jelly Seal, a hemostasis and sealing products; STOP, a non-bleeding intravascular injection; Film that prevents leakage at intestinal and vascular anastomosis sites; InnoLOCK and InTro vascular interventional procedure.